Brokers Set Expectations for Select Medical Q1 Earnings

Select Medical Holdings Co. (NYSE:SEM) – Equities researchers at Zacks Research issued their Q1 2025 earnings per share estimates for shares of Select Medical in a report issued on Thursday, March 6th. Zacks Research analyst Z. Masood expects that the health services provider will earn $0.43 per share for the quarter. The consensus estimate for Select Medical’s current full-year earnings is $1.17 per share. Zacks Research also issued estimates for Select Medical’s Q2 2025 earnings at $0.25 EPS, Q3 2025 earnings at $0.20 EPS, Q4 2025 earnings at $0.27 EPS, FY2025 earnings at $1.15 EPS, Q1 2026 earnings at $0.31 EPS, Q2 2026 earnings at $0.50 EPS, Q3 2026 earnings at $0.32 EPS, Q4 2026 earnings at $0.31 EPS and FY2026 earnings at $1.44 EPS.

Several other analysts have also recently weighed in on the company. UBS Group lowered their price target on Select Medical from $40.00 to $21.00 and set a “neutral” rating on the stock in a report on Friday, January 3rd. StockNews.com raised Select Medical from a “hold” rating to a “buy” rating in a report on Friday, February 21st. Benchmark raised Select Medical from a “hold” rating to a “buy” rating and set a $23.00 price target on the stock in a report on Monday, February 24th. Finally, Royal Bank of Canada lowered their price target on Select Medical from $47.00 to $23.00 and set an “outperform” rating on the stock in a report on Monday, February 24th. One investment analyst has rated the stock with a hold rating and four have issued a buy rating to the company’s stock. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus target price of $27.25.

Select Medical Stock Performance

NYSE:SEM opened at $17.92 on Monday. The business’s 50-day moving average price is $18.94 and its two-hundred day moving average price is $26.87. Select Medical has a twelve month low of $16.20 and a twelve month high of $40.98. The stock has a market cap of $2.31 billion, a P/E ratio of 10.86, a PEG ratio of 0.64 and a beta of 1.56. The company has a quick ratio of 1.13, a current ratio of 1.13 and a debt-to-equity ratio of 1.37.

Select Medical (NYSE:SEM) last issued its quarterly earnings data on Thursday, February 20th. The health services provider reported $0.18 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.29 by ($0.11). The company had revenue of $1.31 billion for the quarter, compared to analysts’ expectations of $1.50 billion. Select Medical had a return on equity of 14.04% and a net margin of 3.23%.

Select Medical Cuts Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, March 13th. Investors of record on Monday, March 3rd will be issued a dividend of $0.0625 per share. The ex-dividend date of this dividend is Monday, March 3rd. This represents a $0.25 dividend on an annualized basis and a dividend yield of 1.40%. Select Medical’s dividend payout ratio is 15.15%.

Hedge Funds Weigh In On Select Medical

A number of large investors have recently modified their holdings of SEM. Principal Financial Group Inc. grew its position in Select Medical by 6.7% during the 3rd quarter. Principal Financial Group Inc. now owns 2,357,823 shares of the health services provider’s stock worth $82,208,000 after acquiring an additional 147,032 shares during the last quarter. Versor Investments LP bought a new position in Select Medical during the 3rd quarter worth approximately $1,245,000. Victory Capital Management Inc. grew its position in Select Medical by 0.6% during the 3rd quarter. Victory Capital Management Inc. now owns 1,181,078 shares of the health services provider’s stock worth $41,184,000 after acquiring an additional 7,372 shares during the last quarter. KBC Group NV grew its position in Select Medical by 4.5% during the 3rd quarter. KBC Group NV now owns 13,050 shares of the health services provider’s stock worth $455,000 after acquiring an additional 563 shares during the last quarter. Finally, Royce & Associates LP grew its position in Select Medical by 0.6% during the 3rd quarter. Royce & Associates LP now owns 346,675 shares of the health services provider’s stock worth $12,089,000 after acquiring an additional 1,910 shares during the last quarter. 89.48% of the stock is owned by hedge funds and other institutional investors.

Select Medical Company Profile

Select Medical Holdings Corporation, through its subsidiaries, operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. It operates in four segments: Critical Illness Recovery Hospital, Rehabilitation Hospital, Outpatient Rehabilitation, and Concentra.